These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406 [TBL] [Abstract][Full Text] [Related]
44. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808 [TBL] [Abstract][Full Text] [Related]
45. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure. Fu S; Xie L; Li D; Ye P; Luo L Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892 [TBL] [Abstract][Full Text] [Related]
46. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke. Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348 [TBL] [Abstract][Full Text] [Related]
47. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease? Kragelund C; Grønning B; Omland T; Køber L; Strande S; Steffensen R; Hildebrandt P Am Heart J; 2006 Mar; 151(3):712.e1-712.e7. PubMed ID: 16504637 [TBL] [Abstract][Full Text] [Related]
48. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy. Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955 [TBL] [Abstract][Full Text] [Related]
50. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization. Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525 [TBL] [Abstract][Full Text] [Related]
51. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Rothenbacher D; Koenig W; Brenner H Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010 [TBL] [Abstract][Full Text] [Related]
52. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure]. Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374 [TBL] [Abstract][Full Text] [Related]
53. Preoperative NT-proBNP independently predicts outcome in patients with acute coronary syndrome undergoing CABG. Holm J; Vidlund M; Vanky F; Friberg O; Håkanson E; Svedjeholm R Scand Cardiovasc J Suppl; 2013 Feb; 47(1):28-35. PubMed ID: 22989031 [TBL] [Abstract][Full Text] [Related]
54. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. Chuang CP; Jong YS; Wu CY; Lo HM Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111 [TBL] [Abstract][Full Text] [Related]
55. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis. Wolber T; Maeder M; Rickli H; Riesen W; Binggeli C; Duru F; Ammann P Eur J Clin Invest; 2007 Jan; 37(1):18-25. PubMed ID: 17181563 [TBL] [Abstract][Full Text] [Related]
56. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial. Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J; Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561 [TBL] [Abstract][Full Text] [Related]
57. [The prognostic value of N-terminal pro-B-type natriuretic peptide in patients with severe sepsis and septic shock]. Zhao HY; Liu F; Lu J; Liu D; An YZ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):467-70. PubMed ID: 21878169 [TBL] [Abstract][Full Text] [Related]
58. N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke. Chang L; Yan H; Li H; Song Z; Gui Y; Yan Z; Li T; Duan D Neuroreport; 2014 Sep; 25(13):985-90. PubMed ID: 25102374 [TBL] [Abstract][Full Text] [Related]
59. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function. Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914 [TBL] [Abstract][Full Text] [Related]
60. Combined effect of serum N-terminal pro-brain natriuretic peptide and galectin-3 on prognosis 1 year after ischemic stroke. Liu Y; Guo D; Wang A; Yang J; Zhu Z; Xu T; Zhong C; Peng H; Chen J; Zhou Y; Zhang Y; He J Clin Chim Acta; 2020 Dec; 511():33-39. PubMed ID: 32986993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]